Dasari A, Shen C, Halperin D, Zhao B, Zhou S, Xu Y, et al. Trends in the incidence, prevalence, and survival outcomes in patients with neuroendocrine tumors in the United States. JAMA Oncol. 2017;3(10):1335–42. https://doi.org/10.1001/jamaoncol.2017.0589.

Article  PubMed  PubMed Central  Google Scholar 

Xu Z, Wang L, Dai S, Chen M, Li F, Sun J, et al. Epidemiologic trends of and factors associated with overall survival for patients with gastroenteropancreatic neuroendocrine tumors in the United States. JAMA Netw Open. 2021;4(9):e2124750. https://doi.org/10.1001/jamanetworkopen.2021.24750.

Article  PubMed  PubMed Central  Google Scholar 

Patel N, Benipal B. Incidence of neuroendocrine tumors in the United States from 2001-2015: a United States cancer statistics analysis of 50 states. Cureus. 2019;11(3):e4322. https://doi.org/10.7759/cureus.4322.

Article  PubMed  PubMed Central  Google Scholar 

• Das S, Dasari A. Epidemiology, incidence, and prevalence of neuroendocrine neoplasms: are there global differences? Curr Oncol Rep. 2021;23(4):43. https://doi.org/10.1007/s11912-021-01029-7. This study describes incidence and prevalence of GEP NET around the world (North America, Europe, Asia), based on data from registries and national studies.

Article  PubMed  PubMed Central  Google Scholar 

Fraenkel M, Kim M, Faggiano A, De Herder WW, Valk GD. Incidence of gastroenteropancreatic neuroendocrine tumours: a systematic review of the literature. Endocr Relat Cancer. 2014;21(3):153–63. https://doi.org/10.1530/ERC-13-0125.

Article  Google Scholar 

Givi B, Pommier SJ, Thompson AK, Diggs BS, Pommier RF. Operative resection of primary carcinoid neoplasms in patients with liver metastases yields significantly better survival. Surgery. 2006;140(6):891–8. https://doi.org/10.1016/j.surg.2006.07.033.

Article  PubMed  Google Scholar 

Cardoso R, Guo F, Heisser T, De Schutter H, Van Damme N, Christina Nilbert M, et al. Overall and stage-specific survival of patients with screen-detected colorectal cancer in European countries: a population-based study in 9 countries. Lancet Reg Heal Eur. 2022;21:100458. https://doi.org/10.1016/j.lanepe.2022.100458.

Article  Google Scholar 

Kacmaz E, Sarasqueta AF, van Eeden S, Dreijerink KMA, Klumpen HJ, Tanis PJ, et al. Update on incidence, prevalence, treatment and survival of patients with small bowel neuroendocrine neoplasms in the Netherlands. World J Surg. 2021;45(8):2482–91. https://doi.org/10.1007/s00268-021-06119-y.

Article  PubMed  PubMed Central  Google Scholar 

Frilling A, Modlin IM, Kidd M, Russell C, Breitenstein S, Salem R, et al. Review Recommendations for management of patients with neuroendocrine liver metastases. Lancet Oncol. 2014;15:e8–21. https://doi.org/10.1016/S1470-2045(13)70362-0.

Article  PubMed  Google Scholar 

•• Bennett S, Coburn N, Law C, Mahar A, Zhao H, Singh S, et al. Upfront small bowel resection for small bowel neuroendocrine tumors with synchronous metastases: a propensity-score matched comparative population-based analysis. Ann Surg. 2022;276(5):e450–8. https://doi.org/10.1097/SLA.0000000000004647. This study performed PSM on a retrospective cohort study and found PTR to prolong survival both before and after PSM was conducted.

Article  PubMed  Google Scholar 

•• Levy S, Arthur JD, Banks M, NFM K, Fenwick SW, Diaz-Nieto R, et al. Primary tumor resection is associated with improved disease-specific mortality in patients with stage IV small intestinal neuroendocrine tumors (NETs): a comparison of upfront surgical resection versus a watch and wait strategy in two specialist NET centers. Ann Surg Oncol. 2022;29(12):7822–32. https://doi.org/10.1245/s10434-022-12030-0. Two institutional study including patients with stage IV SI-NET and PTR or a watch and wait approach based on location. Performed per protocol, intention to treat and instrumental variable analyses trying to mimick a true randomized controlled trial in absence of prospective data. This study found PTR to improve survival in all three types of analyses.

Article  PubMed  Google Scholar 

Halperin DM, Shen C, Dasari A, Xu Y, Chu Y, Zhou S, et al. Frequency of carcinoid syndrome at neuroendocrine tumour diagnosis: a population-based study. Lancet Oncol. 2017;18(4):525–34. https://doi.org/10.1016/S1470-2045(17)30110-9.

Article  PubMed  PubMed Central  Google Scholar 

Grozinsky-Glasberg S, Grossman AB, Gross DJ. Carcinoid heart disease: from pathophysiology to treatment--‘something in the way it moves’. Neuroendocrinology. 2015;101(4):263–73. https://doi.org/10.1159/000381930.

Article  CAS  PubMed  Google Scholar 

Rodriguez Laval V, Pavel M, Steffen IG, Baur AD, Dilz LM, Fischer C, et al. Mesenteric fibrosis in midgut neuroendocrine tumors: functionality and radiological features. Neuroendocrinology. 2018;106(2):139–47. https://doi.org/10.1159/000474941.

Article  CAS  PubMed  Google Scholar 

Daskalakis K, Karakatsanis A, Stalberg P, Norlen O, Hellman P. Clinical signs of fibrosis in small intestinal neuroendocrine tumours. Br J Surg. 2017;104(1):69–75. https://doi.org/10.1002/bjs.10333.

Article  CAS  PubMed  Google Scholar 

• Howe JR, Cardona K, Fraker DL, Kebebew E, Untch BR, Wang YZ, et al. The surgical management of small bowel neuroendocrine tumors: consensus guidelines of the North American Neuroendocrine Tumor Society. Pancreas. 2017;46(6):715–31. https://doi.org/10.1097/MPA.0000000000000846. New consensus guidelines of the North American Neuroendocrine Tumor Society regarding management of SI-NET.

Article  PubMed  PubMed Central  Google Scholar 

• Partelli S, Bartsch K, Capdevila J, Knigge U. ENETS Consensus guidelines for the standards of care in neuroendocrine tumours: surgery for small intestinal and pancreatic neuroendocrine tumours. Neuroendocrinology. 2017;105(3):255–65. https://doi.org/10.1159/000464292. Consensus guidelines regarding surgical management of SI-NET and pancreatic NET according to the European Neuroendocrine Tumor Society.

Article  CAS  PubMed  Google Scholar 

• Pavel M, Öberg K, Falconi M, Krenning EP, Sundin A, Perren A, et al. Gastroenteropancreatic neuroendocrine neoplasms: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2020;31(7):844–60. https://doi.org/10.1016/j.annonc.2020.03.304. Consensus guidelines including treatment and managenement of GEP-NET according to the European Society for Medical Oncology.

Article  CAS  PubMed  Google Scholar 

Gangi A, Anaya DA. Surgical principles in the management of small bowel neuroendocrine tumors. Curr Treat Options Oncol. 2020;21(11):88. https://doi.org/10.1007/s11864-020-00784-2.

Article  PubMed  Google Scholar 

Howe JR. It may not be too little or too late: resecting primary small bowel neuroendocrine tumors in the presence of metastatic disease. Ann Surg Onco. 2020;27(8):2583–5. https://doi.org/10.1245/s10434-020-08695-0.

Article  Google Scholar 

• Rindi G, Mete O, Uccella S, Basturk O, La Rosa S, Brosens LAA, et al. Overview of the 2022 WHO classification of neuroendocrine neoplasms. Endocrine Pathology. 2022;33(1):115–54. https://doi.org/10.1007/s12022-022-09708-2. Newest version of the WHO classification of neuroendocrine tumors.

Article  CAS  PubMed  Google Scholar 

Niederle B, Pape U. ENETS consensus guidelines update for neuroendocrine neoplasms of the jejunum and ileum. Neuroendocrinology. 2016;103(2):125–38. https://doi.org/10.1159/000443170.

Article  CAS  PubMed  Google Scholar 

Amin MB, Greene FL, Edge SB, Compton CC, Gershenwald JE, Brookland RK, et al. The eighth edition AJCC cancer staging manual: continuing to build a bridge from a population-based to a more “personalized” approach to cancer staging. CA Cancer J Clin. 2017;67(2):93–9. https://doi.org/10.3322/caac.21388.

Article  PubMed  Google Scholar 

• Shah MH, Goldner WS, Benson AB, Bergsland E, Blaszkowsky LS, Brocks P, et al. Neuroendocrine and adrenal tumors, version 2.2021, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2021;19(7) https://doi.org/10.6004/jnccn.2021.0032. The National Comprehensive Cancer Network guidelines concerning NET including SI-NET.

Gangi A, Siegel E, Barmparas G, Lo S, Jamil LH, Hendifar A, et al. Multifocality in small bowel neuroendocrine tumors. J Gastrointest Surg. 2017;22(2):303–9. https://doi.org/10.1007/s11605-017-3586-8.

Article  PubMed  Google Scholar 

Norlen O, Stalberg P, Oberg K, Eriksson J, Hedberg J, Hessman O, et al. Long-term results of surgery for small intestinal neuroendocrine tumors at a tertiary referral center. World J Surg. 2012;36(6):1419–31. https://doi.org/10.1007/s00268-011-1296-z.

Article  PubMed  Google Scholar 

Dahdaleh FS, Lorenzen A, Rajput M, Carr JC, Liao J, Menda Y, et al. The value of preoperative imaging in small bowel neuroendocrine tumors. Ann Surg Oncol. 2013;20(6):1912–7. https://doi.org/10.1007/s00268-011-1296-z.

Article  PubMed  Google Scholar 

Deppen SA, Blume J, Bobbey AJ, Shah C, Graham MM, Lee P, et al. 68Ga-DOTATATE compared with 111In-DTPA-octreotide and conventional imaging for pulmonary and gastroenteropancreatic neuroendocrine tumors: a systematic review and meta-analysis. J Nucl Med. 2016;57(6):872–8. https://doi.org/10.2967/jnumed.115.165803.

Article  CAS  PubMed  Google Scholar 

•• Shaib WL, Penely M, Zakka KM, Jiang R, Akce M, Wu C, et al. Role of resection of the primary in metastatic well/intermediate-differentiated neuroendocrine tumor (NET). J Clin Oncol. 2019;37:e15693. https://doi.org/10.1200/JCO.2019.37.15_suppl.e15693. This retrospective cohort study did find PTR to prolong median survival compared to no surgery at the primary site. However, after multivariable analysis PTR was not significantly associated with improved survival.

Article  Google Scholar 

Scott AT, Howe JR. Management of small bowel neuroendocrine tumors. Surg Oncol Clin N Am. 2020;29(2):223–41. https://doi.org/10.1016/j.soc.2019.11.006.

Article  PubMed  Google Scholar 

Cazzato RL, Hubelé F, De Marini P, et al. Liver-directed therapy for neuroendocrine metastases: from interventional radiology to nuclear medicine procedures. Cancers (Basel). 2021;13(24):6368. https://doi.org/10.3390/cancers13246368.

Article  CAS  PubMed  PubMed Central  Google Scholar 

•• Lewis A, Raoof M, PHG I, Williams J, Melstrom L, Li D, et al. Resection of the primary gastrointestinal neuroendocrine tumor improves survival with or without liver treatment. Ann Surg. 2019;270(6):1131–7. https://doi.org/10.1097/SLA.0000000000002809. This retrospective cohort study investigated the role of both PTR and liver directed treatments in patients with stage IV GEP-NET. They found PTR was independently associated with improved survival and increased median survival. Furthermore, a combined treatment of PTR and liver directed therapies improved survival the most.

Article  PubMed  Google Scholar 

•• Gangi A, Manguso N, Gong J, Crystal JS, Paski SC, Hendifar AE, et al. Midgut neuroendocrine tumors with liver-only metastases: benefit of primary tumor resection. Ann Surg Oncol. 2020;27(11):4525–32. https://doi.org/10.1245/s10434-020-08510-w. This retrospective study found PTR to be an independent predictor for survival after multivariable analysis. Median survival was not reached in the group that received PTR due to insufficient follow-up time.

Article  PubMed  Google Scholar 

•• Tierney JF, Chivukula SV, Wang X, Pappas SG, Schadde E, Hertl M, et al. Resection of primary tumor may prolong survival in metastatic gastroenteropancreatic neuroendocrine tumors. Surg (United States). 2019;165(3):644–51. https://doi.org/10.1016/j.surg.2018.09.006. This retrospective cohort study included patients with stage IV GEP-NET and found PTR to an independent predictor for survival in a subset of SI-NET. Furthermore, median survival improved when patients received PTR.

Article  Google Scholar 

•• Polcz M, Schlegel C, Edwards GC, Wang F, Tan M, Kiernan C, et al. Primary tumor resection offers survival benefit in patients with metastatic midgut neuroendocrine tumors. Ann Surg Oncol. 2020;27(8):2795–803. https://doi.org/10.1245/s10434-020-08602-7. This retrospective cohort found PTR to be predictive for improved survival and found median survival to prolong after PTR compared to non-PTR.

Article  PubMed  Google Scholar 

•• Daskalakis K, Karakatsanis A, Hessman O, Stuart HC, Welin S, Tiensuu Janson E, et al. Association of a prophylactic surgical approach to stage IV small intestinal neuroendo